Filip Janku

Company: Monte Rosa Therapeutics

Job title: Chief Medical Officer

Seminars:

Molecular Glue Degraders (MGDs) – From the Bench to the Clinic 10:00 am

MGDs discovered serendipitously have been limited in scope to heme oncology Monte Rosa’s Queen™ platform allows identification of highly selective and oral MGDs that go beyond heme oncology into solid tumors and non-oncology indications, as illustrated by our GSPT1 and VAV1 programsRead more

day: Day Two AM